Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars C Gormsen

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
EJNMMI Research|May 5, 2019
A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CTLars C Gormsen, Mikkel H Vendelbo, Mette Abildgaard Pedersen, et al.
Basic & Clinical Pharmacology & Toxicology|February 27, 2024
Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetesJens Hohwü Voigt, Katrine M Lauritsen, Steen Bønløkke Pedersen, et al.
Hepatology (Baltimore, Md.)|November 13, 2021
The pathophysiology of Wilson's disease visualized: A human <sup>64</sup> Cu PET studyThomas Damgaard Sandahl, Lars C Gormsen, Kristoffer Kjærgaard, et al.
British Journal of Haematology|November 14, 2023
The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM studyMette Abildgaard Pedersen, Lars C Gormsen, Lasse H Jakobsen, et al.
Seminars in Nuclear Medicine|March 27, 2024
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future TrendsKornelis S M van der Geest, Olivier Gheysens, Lars C Gormsen, et al.
British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.
Atherosclerosis|April 3, 2023
Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver diseaseJeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, et al.
Journal of the American Heart Association|March 1, 2017
Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography StudyLars C Gormsen, Mads Svart, Henrik Holm Thomsen, et al.
Journal of Lipid Research|June 20, 2024
Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitisJeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2016
Cholinergic PET imaging in infections and inflammation using <sup>11</sup>C-donepezil and <sup>18</sup>F-FEOBVNis Pedersen Jørgensen, Aage K O Alstrup, Frank V Mortensen, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
EJNMMI Research|May 5, 2019
A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CTLars C Gormsen, Mikkel H Vendelbo, Mette Abildgaard Pedersen, et al.
Basic & Clinical Pharmacology & Toxicology|February 27, 2024
Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetesJens Hohwü Voigt, Katrine M Lauritsen, Steen Bønløkke Pedersen, et al.
Hepatology (Baltimore, Md.)|November 13, 2021
The pathophysiology of Wilson's disease visualized: A human <sup>64</sup> Cu PET studyThomas Damgaard Sandahl, Lars C Gormsen, Kristoffer Kjærgaard, et al.
British Journal of Haematology|November 14, 2023
The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM studyMette Abildgaard Pedersen, Lars C Gormsen, Lasse H Jakobsen, et al.
Seminars in Nuclear Medicine|March 27, 2024
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future TrendsKornelis S M van der Geest, Olivier Gheysens, Lars C Gormsen, et al.
British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.
Atherosclerosis|April 3, 2023
Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver diseaseJeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, et al.
Journal of the American Heart Association|March 1, 2017
Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography StudyLars C Gormsen, Mads Svart, Henrik Holm Thomsen, et al.
Journal of Lipid Research|June 20, 2024
Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitisJeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2016
Cholinergic PET imaging in infections and inflammation using <sup>11</sup>C-donepezil and <sup>18</sup>F-FEOBVNis Pedersen Jørgensen, Aage K O Alstrup, Frank V Mortensen, et al.
Pageof 9